Uterine conservative-resective surgery for selected placenta accreta spectrum cases: Surgical-vascular control methods

Rozi Aditya Aryananda, Aditiawarman Aditiawarman, Khanisyah Erza Gumilar, Manggala Pasca Wardhana, M Ilham Aldika Akbar, Nareswari Cininta, Ernawati Ernawati, Budi Wicaksono, Hermanto Tri Joewono, Erry Gumilar Dachlan, Citra Aulia Bachtiar, Devita Kurniawati, Dian Puspita Virdayanti, Grace Ariani, Gustaaf Albert Dekker, Agus Sulistyono, Rozi Aditya Aryananda, Aditiawarman Aditiawarman, Khanisyah Erza Gumilar, Manggala Pasca Wardhana, M Ilham Aldika Akbar, Nareswari Cininta, Ernawati Ernawati, Budi Wicaksono, Hermanto Tri Joewono, Erry Gumilar Dachlan, Citra Aulia Bachtiar, Devita Kurniawati, Dian Puspita Virdayanti, Grace Ariani, Gustaaf Albert Dekker, Agus Sulistyono

Abstract

Introduction: The incidence of placenta accreta spectrum (PAS) has increased, but the optimal management and the optimal way to achieve vascular control are still controversial. This study aims to compare maternal outcomes between different methods of vascular control in surgical PAS management.

Material and methods: A retrospective cohort study on consecutive cases diagnosed with PAS between 2013 and 2020 in single tertiary hospital. The final diagnosis of PAS was made following preoperative ultrasound and confirmation during surgery. Management of PAS using cesarean hysterectomy with internal iliac artery ligation (IIAL) was compared with two types of vascular control in uterine conservative-resective surgery (IIAL vs identification-ligation of the upper vesical, upper vaginal, and uterine arteries).

Results: Over an 8-year period, 234 pregnant women were diagnosed with PAS meeting the inclusion criteria. Uterine conservative-resective surgery (200 cases) was associated with lower mean blood loss compared with cesarean hysterectomy with IIAL (34 cases) in all PAS cases (1379 ± 769 mL vs 3168 ± 1916 mL; p < 0.001). In sub-analysis of the two uterine conservative-resective surgery subgroups, the group with identification-ligation of the upper vesical, upper vaginal, and uterine arteries had a significantly lower blood loss compared with uterine conservative-resective surgery with IIAL (1307 ± 743 mL vs 1701 ± 813 mL; p = 0.005). Women in the hysterectomy with IIAL group had more massive transfusion (35.3% vs 2.5%; p < 0.001; odds ratio [OR] 21.3, 95% confidence interval [CI] 6.9-66), major blood loss (>1500 mL) (70.6% vs 34%, p < 0.001; OR 4.7; 95% CI 2.1-10.3), catastrophic blood loss (>2500 mL) (64.7% vs 12.5%;p < 0.001; OR 12.8, 95% CI 5.7-29.1), other complications (32% vs 12.4%; p = 0.007; OR 3.4, 95% CI 1.5-7.7), and intensive care unit admission (32.4% vs 1.5%; p < 0.001; OR 31.4, 95% CI 8.2-120.7) compared with the uterine conservative-resective surgery groups. The identification-ligation of the upper vesical, upper vaginal and uterine arteries had a significant lower risk for major blood loss (30.5% vs 50%; p = 0.041; OR 0.44, 95% CI = 0.2-0.9) compared with IIAL for vascular control of uterine conservative-resective surgery.

Conclusions: Cesarean hysterectomy is not the default treatment for PAS, PAS with invasion above the vesical trigone are suitable for uterine conservative-resective surgery with upper vesical, upper vaginal and uterine artery vascular control.

Keywords: placenta accreta spectrum; uterine conservative-resective surgery; vascular control.

Conflict of interest statement

None.

© 2022 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Figures

FIGURE 1
FIGURE 1
Bladder flap using Pelosi maneuver starting from lateral bladder to medial posterior bladder
FIGURE 2
FIGURE 2
Enrollment data based on ultrasound reports, combined medical records, surgical reports, and pathology reports

References

    1. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty‐year analysis. Am J Obstet Gynecol. 2005;192:1458‐1461.
    1. Grechukhina O, Deshmukh U, Fan L, et al. Cesarean scar pregnancy, incidence, and recurrence: five‐year experience at a single tertiary care referral center. Obstet Gynecol. 2018;132:1285‐1295.
    1. Likis FE, Sathe NA, Morgans AK, et al. Management of Postpartum Hemorrhage. Agency for Healthcare Research and Quality (US); 2015.
    1. Palacios Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid S. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand. 2004;83:738‐744.
    1. Chandraharan E, Rao S, Belli A‐M, Arulkumaran S. The triple‐P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117:191‐194.
    1. Sentilhes L, Goffinet F, Kayem G. Management of placenta accreta. Acta Obstet Gynecol Scand. 2013;92:1125‐1134.
    1. American College of Obstetricians and Gynecologists; Society for Maternal‐Fetal Medicine . Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132:e259‐e275.
    1. Committee on Obstetric Practice . Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012;120:207‐211.
    1. Jolley JA, Nageotte MP, Wing DA, Shrivastava VK. Management of placenta accreta: a survey of maternal‐fetal medicine practitioners. J Matern Fetal Neonatal Med. 2012;25:756‐760.
    1. Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115:526‐534.
    1. Provansal M, Courbiere B, Agostini A, D'Ercole C, Boubli L, Bretelle F. Fertility and obstetric outcome after conservative management of placenta accreta. Int J Gynaecol Obstet. 2010;109:147‐150.
    1. Palacios‐Jaraquemada JM, Fiorillo A, Hamer J, Martinez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective‐reconstructive technique. J Matern Fetal Neonatal Med. 2022;35:275‐282.
    1. Collins SL, Stevenson GN, Al‐Khan A, et al. Three‐dimensional power doppler ultrasonography for diagnosing abnormally invasive placenta and quantifying the risk. Obstet Gynecol. 2015;126:645‐653.
    1. Jauniaux E, Bhide A, Kennedy A, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynecol Obstet. 2018;140:274‐280.
    1. Rac MWF, Dashe JS, Wells CE, Moschos E, McIntire DD, Twickler DM. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol. 2015;212:343.e1‐343.e7.
    1. Alfirevic Z, Tang AW, Collins SL, Robson SC, Palacios‐Jaraquemada J, Ad‐hoc International AIP Expert Group . Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol. 2016;47:276‐278.
    1. Nieto‐Calvache AJ, Palacios‐Jaraquemada JM, Aryananda RA. Factors to consider when seeking better results in placenta accreta spectrum. Acta Obstet Gynecol Scand. 2021;100:1932‐1933.
    1. Dannheim K, Shainker SA, Hecht JL. Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. Arch Gynecol Obstet. 2016;293:951‐958.
    1. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence‐based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75‐87.
    1. Palacios‐Jaraquemada JM, D'Antonio F, Buca D, Fiorillo A, Larraza P. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. J Matern Fetal Neonatal Med. 2020;33:3377‐3384.
    1. Cali G, Forlani F, Lees C, et al. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2019;53:752‐760.
    1. di Pasquo E, Ghi T, Calì G, et al. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low‐lying placenta. Ultrasound Obstet Gynecol. 2020;55:460‐466.
    1. Nieto‐Calvache AJ, Palacios‐Jaraquemada JM, Aryananda RA, et al. How to identify patients who require aortic vascular control in placenta accreta spectrum disorders? Am J Obstet Gynecol MFM. 2022;4:100498.
    1. Tan CH, Tay KH, Sheah K, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in Management of Placenta Accreta. Am J Roentgenol. 2007;189:1158‐1163.
    1. Shehata A. Uterine sparing techniques in placenta Accreta. Obstet Gynecol Int J. 2016;5:258‐262.
    1. Yan J, Shi C‐Y, Yu L, Yang H‐X. Folding sutures following tourniquet binding as a conservative surgical approach for placenta previa combined with morbidly adherent placenta. Chin Med J (Engl). 2015;128:2818‐2820.
    1. Cho JY, Kim SJ, Cha KY, Kay CW, Kim MI, Cha KS. Interrupted circular suture: bleeding control during cesarean delivery in placenta previa accreta. Obstet Gynecol. 1991;78:876‐879.
    1. Pelosi MA 3rd, Pelosi MA. Modified cesarean hysterectomy for placenta previa percreta with bladder invasion: retrovesical lower uterine segment bypass. Obstet Gynecol. 1999;93(5 Pt 2):830‐833.
    1. Palacios Jaraquemada JM, Garcia Monaco R, Barbosa NE, Ferle L, Iriarte H, Conesa HA. Lower uterine blood supply: extrauterine anastomotic system and its application in surgical devascularization techniques. Acta Obstet Gynecol Scand. 2007;86:228‐234.
    1. Prevention and Management of Postpartum Haemorrhage: Green‐top Guideline No. 52. BJOG. 2017;124:e106‐e149.
    1. Jadon A, Bagai R. Blood transfusion practices in obstetric anaesthesia. Indian J Anaesth. 2014;58:629‐636.
    1. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol. 2008;21:281‐287.
    1. Patil V, Shetmahajan M. Massive transfusion and massive transfusion protocol. Indian J Anaesth. 2014;58:590‐595.
    1. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145:24‐33.
    1. Laporan Hasil Riset Kesehatan Dasar (Riskesdas). Available from:
    1. Kutuk MS, Ak M, Ozgun MT. Leaving the placenta in situ vs conservative and radical surgery in the treatment of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140:338‐344.
    1. Shih J‐C, Liu K‐L, Kang J, Yang J‐H, Lin M‐W, Yu C‐U. ‘Nausicaa’ compression suture: a simple and effective alternative to hysterectomy in placenta accreta spectrum and other causes of severe postpartum haemorrhage. BJOG. 2019;126:412‐417.
    1. Iwata A, Murayama Y, Itakura A, Baba K, Seki H, Takeda S. Limitations of internal iliac artery ligation for the reduction of intraoperative hemorrhage during cesarean hysterectomy in cases of placenta previa accreta. J Obstet Gynaecol Res. 2010;36:254‐259.
    1. Kaya B, Damarer Z, Guralp O. Is there still a role of internal iliac artery ligation in obstetric hemorrhage with the current rise in popularity of other uterus sparing techniques? Eur J Obstet Gynecol Reprod Biol. 2016;206:e57‐e58.
    1. Polat M, Kahramanoglu I, Senol T, Ozkaya E, Karateke A. Shorter the cervix, more difficult the placenta percreta operations. J Mat Fetal Neonat Med. 2016;29:2327‐2331.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi